Business
Zomedica Expands its TRUVIEW(R) Microscopy Platform with AI Diagnostic Interpretation, Growing its Market Opportunity
Zomedica Expands its TRUVIEW(R) Microscopy Platform with AI Diagnostic Interpretation, Growing its Market Opportunity.
About this update from Zomedica Corp.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Zomedica Expands its TRUVIEW(R) Microscopy Platform with AI Diagnostic Interpretation, Growing its Market Opportunity\r\n \r\n \r\n\r\n\r\nZomedica Expands its TRUVIEW(R) Microscopy Platform with AI Diagnostic Interpretation, Growing its Market Opportunity\r\n\r\n\r\n\r\n\r\n\r\nAI-enabled hematology and cytology analysis improves diagnostic speed, consistency, and workflow efficiency for veterinary clinics ANN ARBOR, MI / ACCESS Newswire / January 23, 2026 / Zomedica Corp. (OTCQB:ZOMDF) (\"Zomedica\" or the \"Company\"), an animal health company providing innovative point-of-care diagnostic and therapeutic solutions for equine and companion animals, today announced the integration of advanced artificial intelligence (AI) interpretation capabilities into its TRUVIEW® AI digital microscopy system.\r\n The AI enhancement expands functionality of the TRUVIEW system by enabling automated interpretation of hematology blood films, with skin and ear cytology to follow shortly. This advance helps veterinary clinics deliver faster and more standardized diagnostic results while improving workflow efficiency. The update is available immediately to existing TRUVIEW subscribers through a software upgrade, with no additional hardware required.\r\n \"With this enhancement, the TRUVIEW microscope evolves beyond automated slide preparation into an intelligent diagnostic platform,\" said William Cambell, Zomedica's Vice President, Imaging, and inventor of the TRUVIEW platform. \"By reducing diagnostic turnaround time and improving consistency, we believe AI-enabled interpretation increases the value of the TRUVIEW platform for high-volume veterinary practices while strengthening our competitive position in point-of-care diagnostics. Importantly, this capability is delivered through software, allowing us to expand functionality while leveraging our existing installed base.\"\r\n Why This Matters to Investors\r\n \r\n Strengthens Platform Differentiation: The addition of AI-powered interpretation expands the TRUVIEW microscope from an automated imaging system into a more comprehensive diagnostic platform, increasing its competitive relevance in the veterinary diagnostics market.\r\n Supports Adoption and Retention: Faster, more consistent diagnostic workflows address key pain points for high-volume veterinary practices, whic...